Literature DB >> 25644983

Prevalence, associated factors and management of insomnia in prison populations: An integrative review.

Lindsay H Dewa1, Simon D Kyle2, Lamiece Hassan3, Jenny Shaw3, Jane Senior3.   

Abstract

Prisoners have many potential risk factors for insomnia including mental ill health and substance misuse. However, literature on prevalence, associated factors and management of insomnia in prison has yet to be systematically examined in this group. The paper objective was to synthesise and appraise the research that examines insomnia in a prison environment. An integrative literature review using thematic analysis was conducted to critically reflect on the current evidence base and outline a prospective research agenda. From the original 384 sourced papers, 33 met the inclusion criteria and were subsequently included for review. Definitions of insomnia and assessment tools used in studies varied considerably making the overall validity of findings uncertain. Notably, no studies used a recommended measure to assess insomnia disorder (ID). Thematic analysis yielded five themes: 1) the varied prevalence of insomnia; 2) the comorbidity of insomnia, psychiatric disorder and substance misuse; 3) the negative influence of prison-related situational and environmental factors on insomnia; 4) the role of hypnotic medication, and, 5) preliminary indications that non-pharmacological treatment can improve sleep. The methodological heterogeneity and variable quality across studies in the assessment of insomnia means conclusive data on prevalence, associated factors and management is lacking. Nonetheless, sleep problems are common and impairing in prison, are linked to comorbid conditions and negatively influenced by the prison environment, which routinely provides limited scope for effective management. Future research in prison populations is needed to reliably identify insomnia prevalence and determine how it can be managed effectively.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hypnotics; Insomnia; Integrative review; Non-pharmacological treatment; Prevalence; Prison

Mesh:

Year:  2014        PMID: 25644983     DOI: 10.1016/j.smrv.2014.12.002

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  7 in total

Review 1.  Mass Incarceration and Pulmonary Health: Guidance for Clinicians.

Authors:  Elizabeth M Viglianti; Theodore J Iwashyna; Tyler N A Winkelman
Journal:  Ann Am Thorac Soc       Date:  2018-04

2.  Prevalence and correlates of sleep problems among Chinese prisoners.

Authors:  Fulei Geng; Jian Wang; Chao Wen; Yuan Shao; Jingguo Wu; Fang Fan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-11       Impact factor: 4.328

3.  Trouble sleeping inside: a cross-sectional study of the prevalence and associated risk factors of insomnia in adult prison populations in England.

Authors:  Lindsay H Dewa; Lamiece Hassan; Jenny J Shaw; Jane Senior
Journal:  Sleep Med       Date:  2017-01-16       Impact factor: 3.492

4.  Poor sleep quality and associated factors among prisoners of the Diredawa correctional facility in eastern Ethiopia.

Authors:  Yibeltal Getachew; Telake Azale; Mogesie Necho
Journal:  Ann Gen Psychiatry       Date:  2020-06-20       Impact factor: 3.455

5.  Design of a treatment pathway for insomnia in prison settings in England: a modified Delphi study.

Authors:  Lindsay H Dewa; Lamiece Hassan; Jenny Shaw; Jane Senior
Journal:  BMJ Open       Date:  2018-08-29       Impact factor: 2.692

6.  Sleep Quality and Psychological Status in a Group of Italian Prisoners.

Authors:  Giulia D'Aurizio; Angelica Caldarola; Marianna Ninniri; Marialucia Avvantaggiato; Giuseppe Curcio
Journal:  Int J Environ Res Public Health       Date:  2020-06-13       Impact factor: 3.390

7.  Sleep Health: An Opportunity for Public Health to Address Health Equity.

Authors:  Lauren Hale; Wendy Troxel; Daniel J Buysse
Journal:  Annu Rev Public Health       Date:  2020-01-03       Impact factor: 21.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.